123 related articles for article (PubMed ID: 37032489)
21. Impact of fasting followed by short-term exposure to interleukin-6 on cytochrome P450 mRNA in mice.
Rasmussen MK; Bertholdt L; Gudiksen A; Pilegaard H; Knudsen JG
Toxicol Lett; 2018 Jan; 282():93-99. PubMed ID: 29030272
[TBL] [Abstract][Full Text] [Related]
22. Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.
Fisher CD; Jackson JP; Lickteig AJ; Augustine LM; Cherrington NJ
Arch Toxicol; 2008 Dec; 82(12):959-64. PubMed ID: 18488193
[TBL] [Abstract][Full Text] [Related]
23. Expression of the CYP3A and CYP2C11 enzymes in a nutritionally obese rodent model: response to phenobarbital treatment.
Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
Int J Obes Relat Metab Disord; 1994 Jun; 18(6):369-74. PubMed ID: 8081427
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of mouse hepatic CYP3A protein by 3-methylcholanthrene does not require cytochrome P450-dependent metabolism.
Lee C; Ding X; Riddick DS
Drug Metab Dispos; 2013 Oct; 41(10):1782-6. PubMed ID: 23846873
[TBL] [Abstract][Full Text] [Related]
25. Induction of hepatic cyp2b and cyp3a subfamily enzymes by nicardipine and nifedipine in mice.
Konno Y; Sekimoto M; Nemoto K; Degawa M
Xenobiotica; 2004 Jul; 34(7):607-18. PubMed ID: 15672751
[TBL] [Abstract][Full Text] [Related]
26. Human gut microbiota influences drug-metabolizing enzyme hepatic Cyp3a: A human flora-associated mice study.
Togao M; Kurakawa T; Tajima S; Wagai G; Ohta-Takada Y; Otsuka J; Kurita A; Kawakami K
J Toxicol Sci; 2023; 48(6):333-343. PubMed ID: 37258238
[TBL] [Abstract][Full Text] [Related]
27. Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes.
Honkakoski P; Negishi M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):889-95. PubMed ID: 9480906
[TBL] [Abstract][Full Text] [Related]
28. Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level.
Cotreau MM; von Moltke LL; Beinfeld MC; Greenblatt DJ
J Pharmacol Toxicol Methods; 2000; 43(1):41-54. PubMed ID: 11091129
[TBL] [Abstract][Full Text] [Related]
29. Intestinal and hepatic expression of cytochrome P450s and mdr1a in rats with indomethacin-induced small intestinal ulcers.
Kawauchi S; Nakamura T; Yasui H; Nishikawa C; Miki I; Inoue J; Horibe S; Hamaguchi T; Tanahashi T; Mizuno S
Int J Med Sci; 2014; 11(12):1208-17. PubMed ID: 25317066
[TBL] [Abstract][Full Text] [Related]
30. Feed-drug interaction of orally applied butyrate and phenobarbital on hepatic cytochrome P450 activity in chickens.
Mátis G; Kulcsár A; Petrilla J; Hermándy-Berencz K; Neogrády Z
J Anim Physiol Anim Nutr (Berl); 2016 Aug; 100(4):637-42. PubMed ID: 26614344
[TBL] [Abstract][Full Text] [Related]
31. Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
Cotreau MM; von Moltke LL; Harmatz JS; Greenblatt DJ
Pharmacology; 2001; 63(4):210-9. PubMed ID: 11729359
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
[TBL] [Abstract][Full Text] [Related]
33. Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.
Kenny JR; Chen L; McGinnity DF; Grime K; Shakesheff KM; Thomson B; Riley R
Xenobiotica; 2008 Dec; 38(12):1500-17. PubMed ID: 18989830
[TBL] [Abstract][Full Text] [Related]
34. Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues.
Puccinelli E; Gervasi PG; La Marca M; Beffy P; Longo V
Xenobiotica; 2010 Aug; 40(8):525-35. PubMed ID: 20509749
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
Charles KA; Rivory LP; Brown SL; Liddle C; Clarke SJ; Robertson GR
Clin Cancer Res; 2006 Dec; 12(24):7492-7. PubMed ID: 17189422
[TBL] [Abstract][Full Text] [Related]
36. Enhanced induction of cytochrome P450 enzymes and CAR binding in TNF (p55(-/-)/p75(-/-)) double receptor knockout mice following phenobarbital treatment.
Van Ess PJ; Mattson MP; Blouin RA
J Pharmacol Exp Ther; 2002 Mar; 300(3):824-30. PubMed ID: 11861787
[TBL] [Abstract][Full Text] [Related]
37. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
[TBL] [Abstract][Full Text] [Related]
38. P450IIB gene expression in rat small intestine: cloning of intestinal P450IIB1 mRNA using the polymerase chain reaction and transcriptional regulation of induction.
Traber PG; Wang W; McDonnell M; Gumucio JJ
Mol Pharmacol; 1990 Jun; 37(6):810-9. PubMed ID: 2359402
[TBL] [Abstract][Full Text] [Related]
39. Constitutive and inducible expression of CYP enzymes in immortal hepatocytes derived from SV40 transgenic mice.
Donato MT; Klocke R; Castell JV; Stenzel K; Paul D; Gómez-Lechón MJ
Xenobiotica; 2003 May; 33(5):459-73. PubMed ID: 12746103
[TBL] [Abstract][Full Text] [Related]
40. Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice.
Park YJ; Lee EK; Lee YK; Park DJ; Jang HC; Moore DD
Toxicol Appl Pharmacol; 2012 Sep; 263(2):131-7. PubMed ID: 22503787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
